protease inhibitor

ARTEMIS: WEEK 48 SAFETY AND EFFICACY OF DARUNAVIR/R BY GENDER, AGE AND RACE

Jaime Andrade-Villanueva 1, Gisela Herrera 2, Philippe Chiliade 3, Ben Van Baelen 4, Eric Lefebvre 5, Ludo Lavreys 41 Hospital Civil de

September 1, 2008

EFFICACY OF DARUNAVIR/RITONAVIR IN TREATMENTEXPERIENCED HIV-1-INFECTED PATIENTS AT 96 WEEKS IN THE POWER 1 AND 2 TRIALS

Pozniak A 1, Jayaweera D 2, Hoy J 3, De Meyer S 4, De Paepe E 4, Spinosa-Guzman S 41 Chelsea and

September 1, 2008